Back to Search Start Over

Adenoid Cystic Carcinoma from the salivary and lacrimal glands and the breast: Different clinical outcomes to the same tumor.

Authors :
Emerick C
Mariano FV
Vargas PA
Nör JE
Squarize CH
Castilho RM
Source :
Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2022 Nov; Vol. 179, pp. 103792. Date of Electronic Publication: 2022 Aug 13.
Publication Year :
2022

Abstract

Adenoid cystic carcinoma (ACC) is a biphasic malignant lesion that can develop at various anatomical sites. Salivary and lacrimal ACC lesions have a high risk of local invasion, metastasis, and poor prognosis. In more distant organs, such as the breast, ACC is a rarer and less aggressive lesion. One of the major predictors of mortality of ACC is perineural invasion, which can be seen in 30 % of breast lesions, 85% of salivary lesions, and almost 100 % of lacrimal gland tumors. The biological differences between these three ACC tumors are still poorly understood. We focused on the current understanding of the genetic variations observed on ACC tumors and prognostic differences associated with distinct anatomical sites. A special effort was made to present the currently available therapies alongside the emerging strategies under development.<br />Competing Interests: Conflict of interest statement The authors have no conflict of interest.<br /> (Copyright © 2022 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1879-0461
Volume :
179
Database :
MEDLINE
Journal :
Critical reviews in oncology/hematology
Publication Type :
Academic Journal
Accession number :
35973662
Full Text :
https://doi.org/10.1016/j.critrevonc.2022.103792